Elbasvir

Overview
Catalog #	bs-75610c-1mg
Product Name	Elbasvir
Specifications
Storage Buffer	Solid
Storage Condition	Stable for 2 years after receipt when stored at -20°C.
Target
Product Information	CAS Number: 1370468-36-2 Molecular formula: C49H55N9O7 Molecular weight: 882 Purity: >98% (HPLC) Appearance: White to off-white solid. Solubility: Soluble in DMSO (20mg/ml), DMF (25mg/ml) or ethanol (25mg/ml). InChiKey: BVAZQCUMNICBAQ-ISSDNXAZSA-N SMILES: O=C(N1CCCC1C2=NC=C(C3=CC4=C(N(C5=C4)[C@@H](OC6=C5C=CC(C7=CN=C(N7)[C@@H]8CCCN8C([C@H](C(C)C)NC(OC)=O)=O)=C6)C9=CC=CC=C9)C=C3)N2)[C@@H](NC(OC)=O)C(C)C
Description	Elbasvir is a direct-acting antiviral drug that potently inhibits hepatitis C virus (HCV) non-structural protein 5A (NS5A). NS5A is essential for HCV RNA synthesis and viral assembly, and elbasvir inhibits the assembly of new viral replicase complexes when used at a concentration of 50 pM. It exhibits potent inhibitory activity against a broad range of HCV genotypes. Formulations containing elbasvir have been used alone and in combination with NS3/4A protease inhibitors in the treatment of HCV. Identified as a potential inhibitor of SARS-CoV-2, responsible for COVID-19.